Fresenius Medical Care AG (ETR:FME) has announced that it will be increasing its dividend from last year's comparable payment on the 27th of May to €1.44. This makes the dividend yield about the same ...

It was a busy week for the biotech sector, with lots of regulatory and pipeline updates amid fears of a global recession ...

Shares of Pacira BioSciences (NASDAQ:PCRX) added ~15% in the postmarket trading on Monday after the company announced an ...

A PharmaSphere Inc. subsidiary didn’t mislead the US Patent and Trademark Office to obtain the patent at the center of an ...

Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb are included in this Analyst Blog.

BioSciences announced that it has settled its litigations with Fresenius Kabi USA, LLC (Fresenius), Jiangsu Hengrui ...

In this article, we are going to take a look at where Fresenius Medical Care AG (NYSE:FMS) stands against other most undervalued healthcare stocks to buy according to analysts. Healthcare prices ...

Fresenius Medical Care AG (ETR:FME – Get Free Report)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of €42.56 ($47.29) and ...

Fresenius, Danone and Proximus benchmarks shake off tariff turmoil ◆ Range of new issue concessions needed ◆ High orderbook ...

Mars announces Helio Fujita as Global P&O VP for Mars Petcare, Fujita will join the Mars Petcare Leadership Team and global ...

The primary driver behind last 12 months revenue was the Fresenius Helios segment contributing a total revenue of €12.7b (58% ...

Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a ...